INS and polycystic ovary syndrome: Significant downregulation (FWER<0.05) of genes in pathways representing OXPHOS and ribosomal proteins in PCOS patients was identified using both GenMAPP and GSEA, and, in part, validated our previous findings, where we used the same cohort of control subjects and 16 insulin resistant PCOS patients [16].